Pharma majors shift slect production to India

After making big-ticket acquisitions abroad, leading Indian pharmaceutical companies like Dr Reddy's Laboratories, Ranbaxy Laboratories, and Aurobindo Pharma are rapidly shifting production to......

Patent row: Ranbaxy takes on IPA

Ranbaxy Laboratories, the biggest member of the Indian Pharmaceutical Alliance, has come out in the open against the alliance's stand on patent issues. The company has come out against the IPA for......

Ranbaxy on an acquisition spree

Having cut eight deals last year, the $1.3 billion pharma major Ranbaxy probably has the sharpest negotiating skills in the business. So, it won't be a surprise if it finally manages to acquire the......

Ranbaxy, Cipla in race for bird flu drug patent

Despite the government granting emergency marketing approval to Swiss drug maker Roche's avian influenza drug Tamiflu, Ranbaxy and Cipla remain in the fray to produce the drug's generic version,......